Follow the money – always follow the money.Synchron Inc is Neuralink’s competitor. Synchron second largest shareholder is Blackrock. Neuralink is owned by Elon Musk.
Anyone who thinks that brain-computer interface in the hands of technocrats, transhumanists, and the NIH will be used exclusively to help the disabled is simply not paying attention. It is a colossal bait and switch humanitarian hoax.
Linda Goudsmit / May 5, 2022
First Human Trials Starts For Brain Computer Interface
by Sarah McBride
May 4, 2022
The first human trials are in view, and it isn’t Elon Musk’s Neuralink Corporation that is leading the charge. Synchron vision is “to transform medicine with unprecedented access to brain data” collected by using the blood vessels of the brain as “natural highways”. It is “the science of restoring, treating, and mapping the electrical activities of the brain.” ⁃ TN Editor
Synchron Inc., which develops a so-called brain-computer interface and competes with Elon Musk’s Neuralink Corp., enrolled the first patient in its U.S. clinical trial, putting the company’s implant on a path toward possible regulatory approval for wider use in people with paralysis.
The early feasibility study is funded by the National Institutes of Health and will evaluate the safety of the device, known as the Stentrode, the New York-based company said. It will also assess how effective the Stentrode is in helping patients control digital devices hands-free.
The trial represents a landmark for Synchron, the first startup working on brain-machine interfaces to begin a clinical trial seeking approval to sell its product. It also puts Synchron ahead of Neuralink, which is better funded but is still recruiting a trial director. Neuralink raised $205 million last year. Synchron has raised $70 million total.
Brain-computer interfaces, or BCI, could empower millions of disabled people to more easily communicate and engage in modern life. Paralysis affects more than 5 million people in the U.S. alone, according to researchers at the Centers for Disease Control. Farther in the future, Musk and other technologists talk of a world where anyone could receive implants to achieve a sort of superintelligence.
Synchron’s device, once implanted, travels to the brain through blood vessels. (Neuralink’s is implanted directly into the skull.) After it reaches the brain, the Stentrode translates brain activity into signals designed to allow texting, emailing, online shopping or other activities using an external device, Synchron said.
In the past, other BCIs have received regulatory approval to treat patients on a temporary basis. Synchron’s trial, if successful, would secure approval from the U.S. Food and Drug Administration for long-term use, not just for experiments like those in a lab.The Synchron study will eventually involve six U.S. patients, split between New York and Pittsburgh. The first patient enrolled this week at Mt. Sinai Hospital in New York. Tom Oxley, Synchron’s founder and chief executive officer, declined to identify the patient or provide demographic details. The next step on the path toward approval would be a wider trial to test for efficacy. If the trials su
Read more at: https://www.bloombergquint.com/onweb/neuralink-rival-synchron-selects-patient-for-brain-computer-trial
Copyright © BloombergQuint
What Is Neuralink?
Neuralink is implantable brain-machine interfaces by Elon Musk.
Some of the most impressive feats in technology we’ve had in recent years have been innovations in artificial intelligence (AI).
AI is reshaping advanced computer systems and technology networks.
As machine learning continues to develop, scientists are looking for new ways to integrate it into our lives — even in our bodies — or more precisely, our brains.
How are they going to do this, though?
Implanted brain-machine interfaces.
For instance, the Neuralink Corporation is looking to create a brain chip that will make the human brain competitive with computers through applications in AI.
Neuralink was founded in 2016 in San Francisco.
Elon Musk, along with several other partners, started the company to treat serious neurological diseases.
Its future ventures will likely include the enhancement of human brains through biologically integrated technologies.
Since the start-up of Neuralink, the company has employed several neuroscientists, chemists, and robotics engineers.
Research and development have been put into the instruments required to connect humans directly to sophisticated tech; however, they have yet to be implemented.
While most people feel that this is an impossible feat, the idea itself is something that Elon Musk and his partners believe in.
Creating a symbiotic relationship between people’s brains and artificial intelligence is appealing to many, which is why the company has had several rounds of funding.
Those rounds of funding have led to large investments from many venture capital firms from around the world.
Among the investors are Valor Equity Partners, Craft Ventures, DFJ Growth, and Dreamers VC.
At this time, the company is still researching and developing the probes, robotics, and other technology required to tackle some of its goals.
In 2021, clinical trials for animals began.
In one interesting example, Neuralink demonstrated the technology in action.
A chimpanzee was shown playing the video game Pong using the Neuralink implant device. With things moving forward for the company, there’s a chance that clinical trials are on the horizon.
This implementation will likely involve small steps, though, as integrating the tech directly at such an early stage could be dicey.
The company itself shares real estate with Elon Musk’s AI company, as well, so the two are likely working together to accelerate advancements.
Who Owns Neuralink?
Elon Musk is the owner of Neuralink.
Neuralink could be his next successful endeavor, but only time will tell.